About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Blogs

Bayer Implements SunGard Adaptiv Solutions to Support Risk Management

Subscribe to our newsletter

Germany’s Bayer AG has implemented a selection of SunGard’s Adaptiv solutions for risk management to ensure it meets the fair value accounting mandates of the International Financial Reporting Standards (IFRS 13) and is ready to comply with European Market Infrastructure Regulation that is expected to come into force later this year.

The German enterprise that specialises in healthcare, agriculture and high-tech materials on a global basis, went live with the SunGard solutions late last year and has completed first quarter reporting with the risk calculation systems.

The company is using SunGard Adaptiv 360 for trade capture, position keeping and to calculate sensitivities. It is also using Adaptiv Analytics to support Monte Carlo based calculations of risk measures such as value at risk, potential future exposure, credit valuation adjustment (CVA) and debt valuation adjustment (DVA). Adaptiv Risk Cube provides Bayer’s risk managers with the means to drill down and analyse risk results, while Adaptiv Operations integrates risk results with back-office functionality and the company’s treasury platform.

The SunGard solutions provide an automated approach to risk calculation and management, replacing a pragmatic method that included manual short cuts and inherent operational risk.

According to Alexander Burck, head of corporate financial control at Bayer, “To help mitigate risks, Bayer decided to use the same risk management methodologies used by some of the largest and most advanced global banks. SunGard’s Adaptiv solutions enable Bayer to determine, monitor and steer its counterparty risk accurately and consistently across its counterparties. With the automated Adaptiv Analytics solution in particular, we are able to calculate Monte Carlo based CVA and DVA and attribute the results accurately to the trade level, even within netting sets, helping us to comply with regulations such as IFRS 13.”

For SunGard, Bayer is a good win in the corporate market. Sven Ludwig, director for risk, SunGard Adaptiv, says: “We see most demand for Adaptiv solutions in capital markets, but more demand is coming from corporate markets where companies are focussing on risk to meet increasing regulation.” Reflecting the corporate sector’s slight lag behind the banking sector in terms of automated risk management, Bayer is reporting on an end-of-day basis on many of its risk measures, but is expected to work with SunGard to meet the emerging banking standard of real-time reporting.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: Navigating a Complex World: Best Data Practices in Sanctions Screening

As rising geopolitical uncertainty prompts an intensification in the complexity and volume of global economic and financial sanctions, banks and financial institutions are faced with a daunting set of new compliance challenges. The risk of inadvertently engaging with sanctioned securities has never been higher and the penalties for doing so are harsh. Traditional sanctions screening...

BLOG

Private Market Data Price Rises Likely as Demand Surges

Demand for private market data is expected to continue rising as the growing popularity of the asset classes accelerates, putting pressure on feed prices. With no end in sight to market volatility and artificial intelligence enabling the sourcing of ever-larger volumes of critical financial and operational information, financial institutions are likely to increase their data...

EVENT

Buy AND Build: The Future of Capital Markets Technology

Buy AND Build: The Future of Capital Markets Technology London examines the latest changes and innovations in trading technology and explores how technology is being deployed to create an edge in sell side and buy side capital markets financial institutions.

GUIDE

AI in Capital Markets Handbook 2026

AI adoption in capital markets has moved into a more disciplined phase. The priority is now controlled deployment: where AI can be used safely, where it can deliver measurable value, and how outputs can be governed, monitored and evidenced. The 2026 edition of the AI in Capital Markets Handbook examines how AI is being applied...